The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1

Clinics

Volumn 62, Issue 4, 2007, Pages 465-476

  Lourenço Jr , Delmar Muniz ^a   Toledo, Rodrigo Almeida ^a   Coutinho, Flavia Lima ^a   Margarido, Leontina Conceição ^a   Siqueira, Sheila Aparecida Coelho ^a   Cortina Gonçalves Dos Santos, Marcelo Augusto ^a   Montenegro, Fabio Luiz De Menezes ^a   Machado, Marcel Cerqueira Cesar ^a   Toledo, Sergio Pereira Almeida ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Genetic diagnosis; MEN1; MEN1 gene; Multiple endocrine neoplasia; Screening

Indexed keywords

EID: 34548788937     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1807-59322007000400014     Document Type: Article

References (56)

1. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-71.
2. Thakker RV. Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am. 2000;29:541-67.
3. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM. 1996;89:653-69.
4. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-61.
5. Metz DC, Jensen RT, Bale AE, Skarulis MC, Eastman RC, Nieman L, et al. In: The Parathyroids: Raven Press, New Your, 1994, p. 591-647
6. Katai M, Sakurai A, Ikeo Y, Hashizume K. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas. Horm Metab Res. 2001;33:499-503.
7. Mallette LE. Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies. Endocrinol Metab Clin North Am. 1994;23:19-36.
8. Burgess JR, David R, Greenaway TM, Parameswaran V, Shepherd JJ. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy. Arch Surg. 1999;134:1119-23.
9. Thompson NW. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med. 1995;238:269-80.
10. Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med. 2005;257:27-37.
11. Glascock MJ, Carty SE. Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance. Surg Oncol. 2002;11:143-50.
12. Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med. 1998;243:465-70.
13. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer. 2005;5:367-75.
14. Grama D, Skogseid B, Wilander E, Eriksson B, Martensson H, Cedermark B, et al. Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg. 1992;16:611-8.
15. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med. 1999;341:635-44.
16. Akerstrom G, Hessman O, Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1. Langenbecks Arch Surg. 2002;386:558-69.
17. Akerstrom G, Hessman O, Hellman P, Skogseid B. Pancreatic tumours as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol. 2005;19:819-30.
18. Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab. 2002;87:457-65.
19. Benson L, Ljunghall S, Akerstrom G, Oberg K. Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med. 1987;82:731-7.
20. Samaan NA, Ouais S, Ordonez NG, Choksi UA, Sellin RV, Hickey RC. Multiple endocrine syndrome type I. Clinical, laboratory findings, and management in five families. Cancer. 1989;64:741-52.
21. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred. J Clin Endocrinol Metab. 1996;81:2642-6.
22. Marx SJ, Vinik AI, Santen RJ, Floyd JC Jr, Mills JL, Green J 3rd. Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred. Medicine (Baltimore). 1986;65:226-41.
23. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab. 2006;91:3316-23.
24. Asteria C, Anagni M, Persani L, Beck-Peccoz P. Loss of heterozygosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas. J Endocrinol Invest. 2001;24:796-801.
25. Teh BT, McArdle J, Chan SP, Menon J, Hartley L, Pullan P, et al. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine (Baltimore). 1997;76:21-9.
26. Teh BT, Zedenius J, Kytola S, Skogseid B, Trotter J, Choplin H, et al. Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg. 1998;228:99-105.
27. Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88:1066-81.
28. Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, et al. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg. 2006;30:643-53.
29. Geerdink EA, Van der Luijt RB, Lips CJ. Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? Eur J Endocrinol. 2003;149:577-82.
30. Skogseid B, Eriksson B, Lundqvist G, Lorelius LE, Rastad J, Wide L, et al. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab. 1991;73:281-7.
31. Skogseid B, Oberg K, Eriksson B, Juhlin C, Granberg D, Akerstrom G, et al. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg. 1996;20:872-6.
32. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404-7.
33. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet. 1997;6:1177-83.
34. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD): 2003 update. Human Mutation. 2003;21:577-81.
35. Turner JJ, Leotlela PD, Pannett AA, Forbes SA, Bassett JH, Harding B, et al. Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol and Metab. 2002;87:2688-93.
36. o Congresso Brasileiro de Endocrinologia e Metabologia, 2006, Recife. Arq Bras Endocrinol Metab. 2006;(50):S639.
37. Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, et al. Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res. 2005;37:369-74.
38. Balogh K, Racz K, Patocs A, Hunyady L.Menin and its interacting proteins: elucidation of menin function. Trends Endocrinol Metab. 2006;17:357-64.
39. Pannett AA, Thakker RV. Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis. J Clin Endocrinol Metab. 2001;86:4371-4.
40. Ohe MN, Santos RO, Barros ER, Lage A, Kunii IS, Abrahao M, et al. Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in Sao Paulo from 1985 to 2002. Braz J Med Biol Res. 2005;38:1383-7.
41. Jorge BH, Agarwal SK, Lando VS, Salvatori R, Barbero RR, Abelin N, et al. Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gs alpha, and Gi2 alpha genes in isolated familial acromegaly. J Clin Endocrinol Metab. 2001;86:542-4.
42. Lourenço Jr, DM, Toledo SPA. Neuroendocrinologia Clínica e Cirúrgica. In: Liberman & Cukier. Neuroendocrinologia Clínica e Cirúrgica. São Paulo : Lemos Editora, 2002. p.577.
43. Lourenço-Jr DM, Toledo SPA, Toledo RA. Neoplasia Endócrina Múltipla tipo 1. In: Tratado de Clinica Médica.São Paulo: Roca, 2006. p.3535.
44. Toledo RA, Lourenco Jr DM, Coutinho FL, Cavalcanti MG, Quedas E, Silva MER, et al. A Importância do Diagnóstico Molecular na Identificação de Fenocópias em Neoplasia Endócrina Múltipla Tipo 1. Arq Bras Endocrinol Metab 2006;(50):S619.
45. Lourenco Jr DM, Coutinho FL, Toledo RA, Quedas E, Cavalcanti MG, Montenegro, F, et al. Hiperparatieoidismo Assintomático (HPTa) na Neoplasia Endócrina Múltipla Tipo 1 (NEM-1). Arq Bras Endocrinol Metab. 2006;(50):S608.
46. Toledo RA, Lourenco Jr DM, Coutinho FL, Quedas E, Longuini VC, Moraes MB, et al. Estudo Gênico em pacientes com Neoplasia Endócrina Múltipla Tipo 1 (NEM-1). Arq Bras Endocrinol Metab. 2006;(50):S497.
47. Cote GJ, Lee JE, Evans DB, Huang E, Schultz PN, Dang GT, et al. Five novel mutations in the familial multiple endocrine neoplasia type 1 (MEN1) gene. Human Mutation. 1998;12:219.
48. Burgess JR, Nord B, David R, Greenaway TM, Parameswaran V, Larsson C, et al. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN1).Clin Endocrinol (Oxf). 2000;53:205-11.
49. Hai N, Aoki N, Shimatsu A, Mori T, Kosugi S. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1. Clin Endocrinol (Oxf). 2000;52:509-18.
50. Lairmore TC, Piersall LD, De Benedetti MK, Dilley WG, Mutch MG, Whelan AJ et al. Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN1). Ann Sug. 2004;239:637-45.
51. Toledo SP, dos Santos MA, Toledo Rde A, Lourenco Junior DM. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2. Clinics. 2006;61:59-70.
52. Santos MA, Nunes AB, Abelin N, Ezabella MC, Toledo Rde A, Toledo SP. Genetic screening of multiple endocrine neoplasia type 2: Experience of the USP Endocrine Genetics Unit. Arq Bras Endocrinol Metabol. 2006;50:7-16.
53. Stabenow E, Tavares MR, Ab'Saber AM, Parra-Cuentas ER, de Matos LL, Eher EM, et al. Angiogenesis as an indicator of metastatic potential in papillary thyroid carcinoma. Clinics. 2005;60:233-40.
54. Durazzo MD, de Araujo CE, Brandao Neto Jde S, Potenza Ade S, Costa P, Takeda F, et al. Clinical and epidemiological features of oral cancer in a medical school teaching hospital from 1994 to 2002: increasing incidence in women, predominance of advanced local disease, and low incidence of neck metastases. Clinics. 2005;60:293-8.
55. Silva RV, Garicochea B, Cotti G, Maranho IC, Cutait R. Hereditary nonpolyposis colorectal cancer identification and surveillance of high-risk families. Clinics. 2005;60:251-6.
56. Waisberg J, de Matos LL, Dos Santos HV, Dos Santos AB, Reis GC, Capelozzi VL. Pancreatic carcinoid: a rare cause of diarrheagenic syndrome. Clinics. 2006;61:175-8.